146 related articles for article (PubMed ID: 9455457)
21. [Preventive efficacies of china-made tropisetron hydrochloride and Navoban on chemotherapy-induced nausea and vomiting: a randomized controlled clinical trial].
Xie M; Wu HY; Guo Y; Liu JL; Guan ZZ; Liu YL; Wang PH; Chen Q; Huang P; Yang JW
Ai Zheng; 2005 Aug; 24(8):998-1001. PubMed ID: 16086881
[TBL] [Abstract][Full Text] [Related]
22. Control of nausea and vomiting by Navoban (tropisetron) in 131 children receiving cytotoxic chemotherapy.
Benoit Y; Hulstaert F; Vermylen C; Sariban E; Hoyoux C; Uyttebroeck A; Otten J; Laureys G; De Kerpel I; Nortier D
Anticancer Drugs; 1995 Feb; 6 Suppl 1():9-14. PubMed ID: 7749170
[TBL] [Abstract][Full Text] [Related]
23. 5HT3-receptor antagonists as antiemetics in cancer.
Drug Ther Bull; 2005 Aug; 43(8):57-62. PubMed ID: 16111085
[TBL] [Abstract][Full Text] [Related]
24. Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting.
Hulstaert F; Van Belle S; Bleiberg H; Canon JL; Dewitte M; Buyse M; De Keyser P; Westelinck KJ
J Clin Oncol; 1994 Nov; 12(11):2439-46. PubMed ID: 7964961
[TBL] [Abstract][Full Text] [Related]
25. [Ondansetron (GR 38032F), a competitive 5-HT3 receptor antagonist as an antiemetic in cytostatic drug-induced nausea and vomiting. An open, substance-oriented phase II/III study].
Serve H; Perker M; Ertl A; Reichold M; Fink U; Berdel WE
Onkologie; 1990 Oct; 13(5):369-74. PubMed ID: 2150552
[TBL] [Abstract][Full Text] [Related]
26. A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting.
Falkson G; van Zyl AJ
Cancer Chemother Pharmacol; 1989; 24(3):193-6. PubMed ID: 2544309
[TBL] [Abstract][Full Text] [Related]
27. Antiemetic action of 5-HT3 receptor antagonists: review of preclinical and clinical results with ICS 205-930.
Gamse R
Cancer Treat Rev; 1990 Sep; 17(2-3):301-5. PubMed ID: 2272046
[TBL] [Abstract][Full Text] [Related]
28. The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation.
Or R; Drakos P; Nagler A; Naparstek E; Kapelushnik J; Cass Y
Support Care Cancer; 1994 Jul; 2(4):245-8. PubMed ID: 8087443
[TBL] [Abstract][Full Text] [Related]
29. Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapy.
Benoit Y; Hulstaert F; Vermylen C; Sariban E; Hoyoux C; Uyttebroeck A; Otten J; Laureys G; De Kerpel I; Nortier D
Med Pediatr Oncol; 1995 Dec; 25(6):457-62. PubMed ID: 7565308
[TBL] [Abstract][Full Text] [Related]
30. Tropisetron (Navoban) in the control of nausea and vomiting induced by combined cancer chemotherapy in children.
Ozkan A; Yildiz I; Yüksel L; Apak H; Celkan T
Jpn J Clin Oncol; 1999 Feb; 29(2):92-5. PubMed ID: 10089950
[TBL] [Abstract][Full Text] [Related]
31. Prevention of emesis by tropisetron in children receiving combined chemotherapy with cisplatin.
Berberoglu S
Pediatr Hematol Oncol; 1995; 12(5):479-83. PubMed ID: 8519633
[TBL] [Abstract][Full Text] [Related]
32. [Prevention and treatment of postoperative nausea and postoperative vomiting with tropisetron].
Hennes HJ
Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Oct; 32(10):628-31. PubMed ID: 9445562
[No Abstract] [Full Text] [Related]
33. Tropisetron (Navoban): just another "setron"?
Aapro MS
Semin Oncol; 1994 Oct; 21(5 Suppl 9):1-2. PubMed ID: 9113118
[No Abstract] [Full Text] [Related]
34. Efficacy of tropisetron (Navoban) in controlling emesis induced in children by anti-cancer therapy.
Rosso P; Cordero di Montezemolo L; Vivenza C; Nasi C; Tonello M; Valle P; Madon E
Tumori; 1994 Dec; 80(6):459-63. PubMed ID: 7900236
[TBL] [Abstract][Full Text] [Related]
35. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
Slabý J; Trnený M; Procházka B; Klener P
Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
[TBL] [Abstract][Full Text] [Related]
36. Comparison of tropisetron and chlorpromazine combinations in the control of nausea and vomiting of patients with advanced cancer.
Mystakidou K; Befon S; Liossi C; Vlachos L
J Pain Symptom Manage; 1998 Mar; 15(3):176-84. PubMed ID: 9564119
[TBL] [Abstract][Full Text] [Related]
37. On-demand antiemetic treatment with the serotonine antagonist tropisetron in cisplatin-treated cancer patients.
Havsteen H; Andersen LJ; Kjaer M; Dalmark M
Anticancer Drugs; 1994 Aug; 5(4):410-8. PubMed ID: 7949244
[TBL] [Abstract][Full Text] [Related]
38. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
[TBL] [Abstract][Full Text] [Related]
39. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
[TBL] [Abstract][Full Text] [Related]
40. [Recent improvements in antiemetic therapy].
Roila F; Palladino MA; Ciccarese G; Basurto C
Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]